Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-01-05 Sale | 2026-01-05 9:50 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick COO | 49,493 | $63.11 | $3,123,349 | 474,908 (Direct) | View |
| 2026-01-05 Sale | 2026-01-05 9:41 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Hamilton James C Chief Medical Officer | 40,164 | $63.11 | $2,534,661 | 171,958 (Direct) | View |
| 2026-01-02 Sale | 2026-01-05 9:39 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 13,187 | $66.1 | $871,703 | 3,792,739 (Direct) | View |
| 2025-12-29 Sale | 2025-12-30 5:46 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 51,726 | $69.13 | $3,575,575 | 3,822,471 (Direct) | View |
| 2025-12-26 Sale | 2025-12-30 5:46 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Ferrari Mauro Director | 7,530 | $70 | $527,100 | 69,053 (Direct) | View |
| 2025-12-19 Sale | 2025-12-23 6:01 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Waddill William D. Director | 8,367 | $67.65 | $566,038 | 56,563 (Direct) | View |
| 2025-12-19 Sale | 2025-12-23 6:01 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Vakiener Victoria Director | 10,040 | $67.68 | $679,491 | 35,723 (Direct) | View |
| 2025-12-19 Sale | 2025-12-23 6:01 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 26,031 | $68.04 | $1,771,022 | 3,805,926 (Direct) | View |
| 2025-12-19 Sale | 2025-12-23 6:01 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | OLUKOTUN ADEOYE Y Director | 10,000 | $67.66 | $676,623 | 33,600 (Direct) | View |
| 2025-12-17 Sale | 2025-12-19 6:56 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 85,000 | $64.04 | $5,443,462 | 3,831,957 (Direct) | View |
| 2025-12-15 Sale | 2025-12-16 1:14 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 184,298 | $67 | $12,348,802 | 3,916,957 (Direct) | View |
| 2025-12-05 Sale | 2025-12-09 6:04 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director | 16,250 | $61.03 | $991,738 | 115,240 (Direct) | View |
| 2025-11-28 Sale | 2025-12-01 6:10 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Ferrari Mauro Director | 8,750 | $56.39 | $493,413 | 68,764 (Direct) | View |
| 2025-10-01 Sale | 2025-10-03 6:15 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Hamilton James C Chief Medical Officer | 20,000 | $35 | $700,000 | 212,122 (Direct) | View |
| 2025-09-12 Sale | 2025-09-16 6:06 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Hamilton James C Chief Medical Officer | 15,000 | $30 | $450,000 | 232,122 (Direct) | View |
| 2025-09-02 Sale | 2025-09-04 5:37 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Hamilton James C Chief Medical Officer | 15,000 | $25 | $375,000 | 247,122 (Direct) | View |
| 2025-08-13 Sale | 2025-08-15 5:59 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Hamilton James C Chief Medical Officer | 10,000 | $20 | $200,000 | 262,122 (Direct) | View |
| 2025-04-09 Sale | 2025-04-11 6:20 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 141,122 | $10.87 | $1,533,337 | 3,921,255 (Direct) | View |
| 2025-03-13 Sale | 2025-03-17 5:45 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 51,425 | $15.07 | $774,975 | 4,062,377 (Direct) | View |
| 2025-03-03 Sale | 2025-03-05 6:32 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 300,000 | $17.58 | $5,274,334 | 4,010,587 (Direct) | View |
| 2025-01-23 Sale | 2025-01-27 7:22 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | OLUKOTUN ADEOYE Y Director | 959 | $21 | $20,139 | 35,781 (Direct) | View |
| 2025-01-06 Sale | 2025-01-07 9:28 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Hamilton James C Chief Discovery/Trans Medicine | 32,729 | $19.82 | $648,824 | 272,122 (Direct) | View |
| 2025-01-06 Sale | 2025-01-07 9:28 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick COO and General Counsel | 37,184 | $19.8 | $736,059 | 527,201 (Direct) | View |
| 2025-01-06 Sale | 2025-01-07 9:27 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer | 45,167 | $19.77 | $893,095 | 455,433 (Direct) | View |
| 2025-01-02 Sale | 2025-01-06 6:07 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 11,520 | $19.05 | $219,456 | 3,764,252 (Direct) | View |
| 2024-12-27 Sale | 2024-12-30 5:12 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | OLUKOTUN ADEOYE Y Director | 2,850 | $20 | $57,000 | 36,740 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-01-06 Option Award | 2026-01-08 6:45 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Hamilton James C Chief Medical Officer | 75,000 | $0 | 246,958 (Direct) | View |
| 2026-01-06 Option Award | 2026-01-08 6:45 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Apel Daniel Joseph Chief Financial Officer | 75,000 | $0 | 176,200 (Direct) | View |
| 2026-01-06 Option Award | 2026-01-08 6:45 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick COO | 75,000 | $0 | 547,408 (Direct) | View |
| 2026-01-06 Gift | 2026-01-08 6:45 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick COO | 980 | $0 | 547,408 (Direct) | View |
| 2025-12-31 Gift | 2026-01-05 9:50 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick COO | 560 | $0 | 474,908 (Direct) | View |
| 2025-12-29 Exercise | 2025-12-30 5:46 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 51,726 | $6.15 | 3,822,471 (Direct) | View |
| 2025-12-29 Exercise | 2025-12-30 5:46 pm | 2016-01-01 2026-01-01 | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 51,726 | $0 | 3,822,471 (Direct) | View |
| 2025-12-16 Option Award | 2025-12-18 6:40 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Ferrari Mauro Director | 7,819 | $0 | 76,583 (Direct) | View |
| 2025-12-16 Option Award | 2025-12-18 6:40 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Lu Hongbo Director | 7,819 | $0 | 54,982 (Direct) | View |
| 2025-12-16 Option Award | 2025-12-18 6:40 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director | 7,819 | $0 | 123,059 (Direct) | View |
| 2025-12-16 Option Award | 2025-12-18 6:40 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Vakiener Victoria Director | 7,819 | $0 | 45,763 (Direct) | View |
| 2025-12-16 Option Award | 2025-12-18 6:39 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | INGRAM DOUGLAS S Director | 7,819 | $0 | 46,215 (Direct) | View |
| 2025-12-16 Option Award | 2025-12-18 6:39 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | OLUKOTUN ADEOYE Y Director | 7,819 | $0 | 43,600 (Direct) | View |
| 2025-12-16 Option Award | 2025-12-18 6:35 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Waddill William D. Director | 7,819 | $0 | 64,930 (Direct) | View |
| 2025-12-12 Option Award | 2025-12-16 1:14 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 180,000 | $0 | 3,916,957 (Direct) | View |
Ownership | 2025-08-12 5:49 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Apel Daniel Joseph Chief Financial Officer | 0 | $0 | 101,200 (Direct) | View |
| 2025-03-13 Option Award | 2025-03-17 5:45 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 340,000 | $0 | 4,062,377 (Direct) | View |
| 2025-03-03 Exercise | 2025-03-05 6:32 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 300,000 | $7.75 | 4,010,587 (Direct) | View |
| 2025-03-03 Exercise | 2025-03-05 6:32 pm | 2015-03-06 2025-03-06 | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 300,000 | $0 | 4,010,587 (Direct) | View |
| 2025-02-07 Option Award | 2025-02-10 6:23 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 9,550 | $20.1 | 3,773,802 (Direct) | View |
| 2025-02-06 Option Award | 2025-02-07 5:57 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | INGRAM DOUGLAS S Director | 38,396 | $20.09 | 38,396 (Direct) | View |
Ownership | 2025-02-07 5:57 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | INGRAM DOUGLAS S Director | 0 | $0 | 0 (Direct) | View |
| 2025-01-04 Option Award | 2025-01-07 9:28 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Hamilton James C Chief Discovery/Trans Medicine | 100,000 | $0 | 272,122 (Direct) | View |
| 2025-01-04 Option Award | 2025-01-07 9:28 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick COO and General Counsel | 100,000 | $0 | 527,201 (Direct) | View |
| 2025-01-04 Option Award | 2025-01-07 9:27 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer | 100,000 | $0 | 455,433 (Direct) | View |